Barclays Maintains Underweight on Clorox, Lowers Price Target to $85

Benzinga Newsdesk www.benzinga.com Negative 87.7%

Neg 87.7% Neu 0% Pos 0%

Barclays analyst Lauren Lieberman maintains Clorox (NYSE:CLX) with a Underweight and lowers the price target from $102 to $85.